When are moderate or high intensity dose statins recommended for patients over age 75?

The recommendation for moderate or high-intensity dose statins for patients over age 75 is based on clinical indication, not as a blanket policy for all seniors or based on family requests. Clinically indicated situations may include factors such as the patient's overall cardiovascular risk, the presence of atherosclerotic cardiovascular disease (ASCVD), or other relevant medical conditions that warrant the use of statins for their potential benefits in reducing cardiovascular events.

For instance, evidence suggests that statins can be beneficial in reducing the risk of stroke, heart attack, and other cardiovascular complications in older adults, particularly those who have existing cardiovascular conditions. Therefore, the decision to initiate or continue statin therapy should be made based on individual assessments of risks and benefits, rather than on the patient's age alone or on the wishes of family members. This personalized approach ensures that treatment aligns with the specific health profile and needs of the patient.